SCHEMBL13826480

SCHEMBL13826480

Cc1c(-n2c(-c3ccc(-c4ccccc4)cc3)nc3ccccc32)c(C)c(-n2c(-c3ccc(-c4ccccc4)cc3)nc3ccccc32)c(C)c1-n1c(-c2ccc(-c3ccccc3)cc2)nc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
KDM4E B2RXH2 8/20 0.49
HSD17B10 Q99714 5/20 0.49
HTT P42858 2/20 0.49
MAPK1 P28482 1/20 0.49
GRIA1 P42261 1/20 0.48
CACNG8 Q8WXS5 1/20 0.48
CACNG2 Q9Y698 1/20 0.48
ALDH1A1 P00352 6/20 0.47
HPGD P15428 4/20 0.47
TP53 P04637 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
PKM P14618 2/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
PDE6D O43924 1/20 0.47
ALDH2 P05091 1/20 0.47
ALDH3A1 P30838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13826483 0.97 ESR1 (0.59) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL22461713 0.88 ESR1 (0.65) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL13299511 0.84 ESR1 (0.54) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL13299513 0.83 ESR1 (0.56) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL14160911 0.83 ESR1 (0.73) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL26344978 0.81 ESR1 (0.51) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL13826714 0.81 ESR1 (0.48) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL16692234 0.81 ESR2 (0.71) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL10041513 0.81 ESR2 (0.71) ESR1ESR2KDM4EHSD17B10HTT
SCHEMBL13299593 0.81 ESR1 (0.54) ESR1ESR2KDM4EHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9735371-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2017-08-15 US disclosed
US-9735371-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2017-08-15 US disclosed
US-20170179399-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-22 US disclosed
US-20170179399-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-22 US disclosed
EP-2699641-B1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-05-17 EP disclosed
US-20140231715-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) 2014-08-21 US disclosed
US-20140231715-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) 2014-08-21 US disclosed
WO-2012143079-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179399-A1 COMPOUNDS FOR ELECTRONIC DEVICES CYP2C19, CYP1B1, CYP2C9 ESR1 40/4885ESR2 275/4885KDM4E 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.